Zaklina Strezoska

Zaklina Strezoska is a highly experienced professional in the field of genomics and gene editing, currently serving as the Director of CRISPR Product Development at Integrated DNA Technologies since August 2024. Strezoska previously held the position of Director of R&D at Revvity, where leadership was provided to R&D teams on innovative gene editing and modulation projects. Prior roles included Manager of R&D at Horizon Discovery, where product lines such as CRISPRa were successfully launched, and Senior Scientist at GE Healthcare, leading gene modulation projects. Strezoska's career also includes significant contributions as a Senior Scientist at Thermofisher Scientific and a project leader at Altana Pharma Research Institute. Strezoska earned a PhD in Molecular Genetics from the University of Illinois Chicago.